DBV Technologies S.A. (NASDAQ:DBVT – Get Free Report)’s stock price passed above its 50-day moving average during trading on Friday . The stock has a 50-day moving average of $3.54 and traded as high as $4.58. DBV Technologies shares last traded at $4.34, with a volume of 36,372 shares changing hands.
Wall Street Analyst Weigh In
Several research analysts have recently commented on DBVT shares. JMP Securities reissued a “market outperform” rating and set a $10.00 price objective on shares of DBV Technologies in a report on Friday, January 10th. StockNews.com assumed coverage on shares of DBV Technologies in a research note on Saturday. They issued a “hold” rating for the company. Finally, HC Wainwright raised their price objective on shares of DBV Technologies from $25.00 to $35.00 and gave the company a “buy” rating in a research report on Thursday, October 24th.
Check Out Our Latest Research Report on DBVT
DBV Technologies Trading Down 1.4 %
DBV Technologies (NASDAQ:DBVT – Get Free Report) last released its earnings results on Wednesday, November 6th. The company reported ($0.80) earnings per share for the quarter, topping analysts’ consensus estimates of ($1.90) by $1.10. DBV Technologies had a negative return on equity of 106.07% and a negative net margin of 815.73%. The company had revenue of $1.07 million during the quarter, compared to the consensus estimate of $1.17 million. On average, equities analysts anticipate that DBV Technologies S.A. will post -7.05 earnings per share for the current fiscal year.
About DBV Technologies
DBV Technologies SA, a clinical-stage biopharmaceutical company, engages in the research and development of epicutaneous immunotherapy products. Its product pipeline comprising Viaskin Peanut, an immunotherapy product, which has completed Phase 3 clinical trial for the treatment of peanut allergies; and Viaskin Milk which is in Phase 1/2 clinical trial for the treatment of immunoglobulin E (IgE) mediated or cow’s milk protein allergy and eosinophilic esophagitis.
See Also
- Five stocks we like better than DBV Technologies
- Roth IRA Calculator: Calculate Your Potential Returns
- Why Energy Transfer Stock Could Soar to New Highs in 2025
- With Risk Tolerance, One Size Does Not Fit All
- 3 Buy-and-Hold Stocks for Long-Term Growth
- 5 discounted opportunities for dividend growth investors
- Despite Short-Term Risks Freeport McMoran Worth a Look
Receive News & Ratings for DBV Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DBV Technologies and related companies with MarketBeat.com's FREE daily email newsletter.